US Stock MarketDetailed Quotes

Adaptive Biotechnologies (ADPT)

Watchlist
  • 19.060
  • +1.490+8.48%
Close Jan 22 16:00 ET
2.91BMarket Cap-36.65P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adaptive Biotechnologies (ADPT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
73.67%-7.13M
28.16%-12.43M
25.73%-28.48M
39.09%-95.21M
53.62%-12.49M
42.03%-27.07M
26.55%-17.3M
35.16%-38.35M
15.02%-156.32M
10.28%-26.93M
Net income from continuing operations
129.74%9.55M
44.66%-25.59M
37.24%-29.83M
29.16%-159.6M
51.46%-33.72M
36.22%-32.1M
3.27%-46.25M
17.62%-47.53M
-12.45%-225.3M
-72.94%-69.47M
Depreciation and amortization
-4.05%4.41M
-10.01%4.5M
-9.26%4.73M
-13.38%19.26M
-17.51%4.45M
-20.34%4.59M
-11.50%5M
-3.85%5.21M
6.27%22.23M
2.01%5.39M
Other non cash items
-97.02%56K
-32.50%1.3M
-29.48%1.67M
-35.15%8.04M
-14.45%1.86M
-49.35%1.88M
-36.73%1.93M
-31.52%2.37M
51.25%12.39M
1.68%2.17M
Change In working capital
-159.98%-33.87M
-287.72%-5.31M
-56.64%-16.14M
62.21%-17.45M
186.93%3.05M
30.13%-13.03M
529.40%2.83M
57.89%-10.31M
35.45%-46.18M
66.50%-3.51M
-Change in receivables
89.70%-536K
-110.95%-702K
54.00%-1.86M
-284.25%-3.74M
86.71%-899K
-1,658.08%-5.2M
1,132.37%6.41M
-144.60%-4.05M
108.97%2.03M
49.91%-6.77M
-Change in inventory
-179.38%-1.35M
111.61%95K
-76.24%264K
289.29%5.37M
-14.96%3.38M
721.61%1.7M
-1,358.46%-818K
116.82%1.11M
-447.37%-2.84M
31.30%3.98M
-Change in prepaid assets
-80.41%-2.52M
50.20%-497K
-67.83%489K
104.30%83K
-52.80%960K
67.69%-1.4M
-239.00%-998K
531.82%1.52M
-154.35%-1.93M
-31.05%2.03M
-Change in payables and accrued expense
10,093.22%5.9M
703.19%3.27M
-145.24%-9.67M
112.41%671K
-20.13%4.26M
97.90%-59K
-94.87%407K
75.18%-3.94M
-176.04%-5.41M
-49.30%5.34M
-Change in other working capital
-338.56%-35.36M
-243.29%-7.47M
-8.56%-5.37M
47.85%-19.84M
42.51%-4.65M
30.31%-8.06M
71.57%-2.18M
53.89%-4.94M
37.00%-38.04M
39.95%-8.1M
Cash from discontinued investing activities
Operating cash flow
73.67%-7.13M
28.16%-12.43M
25.73%-28.48M
39.09%-95.21M
53.62%-12.49M
42.03%-27.07M
26.55%-17.3M
35.16%-38.35M
15.02%-156.32M
10.28%-26.93M
Investing cash flow
Cash flow from continuing investing activities
226.90%17.28M
-43.07%3.35M
-42.54%25.57M
-40.00%77.79M
589.71%22.12M
-79.77%5.29M
-84.25%5.88M
-29.33%44.51M
4,362.89%129.65M
103.29%3.21M
Net PPE purchase and sale
-18.90%-409K
62.12%-655K
16.68%-1.26M
65.75%-3.66M
93.84%-80K
87.62%-344K
53.23%-1.73M
48.32%-1.51M
34.57%-10.7M
48.94%-1.3M
Net investment purchase and sale
214.19%17.69M
-47.40%4M
-41.69%26.83M
-41.96%81.46M
392.76%22.2M
-80.53%5.63M
-81.46%7.61M
-30.17%46.02M
628.91%140.34M
104.74%4.51M
Cash from discontinued investing activities
Investing cash flow
226.90%17.28M
-43.07%3.35M
-42.54%25.57M
-40.00%77.79M
589.71%22.12M
-79.77%5.29M
-84.25%5.88M
-29.33%44.51M
4,362.89%129.65M
103.29%3.21M
Financing cash flow
Cash flow from continuing financing activities
4,110.00%1.68M
5,266.67%1.61M
12,288.64%5.45M
-89.27%241K
45.98%127K
135.29%40K
-97.96%30K
-93.45%44K
-98.30%2.25M
1,350.00%87K
Proceeds from stock option exercised by employees
4,110.00%1.68M
5,266.67%1.61M
12,288.64%5.45M
-89.27%241K
45.98%127K
135.29%40K
-97.96%30K
-93.45%44K
-71.55%2.25M
-72.98%87K
Cash from discontinued financing activities
Financing cash flow
4,110.00%1.68M
5,266.67%1.61M
12,288.64%5.45M
-89.27%241K
45.98%127K
135.29%40K
-97.96%30K
-93.45%44K
-98.30%2.25M
1,350.00%87K
Net cash flow
Beginning cash position
-26.94%45.88M
-28.09%53.36M
-25.26%50.82M
-26.43%68M
-55.19%41.06M
-44.01%62.8M
-23.45%74.2M
-26.43%68M
-34.54%92.43M
-58.35%91.63M
Current changes in cash
154.47%11.84M
34.42%-7.47M
-59.03%2.54M
29.69%-17.18M
141.27%9.76M
-5.89%-21.74M
-174.80%-11.4M
37.81%6.2M
49.91%-24.43M
81.47%-23.64M
End cash Position
40.58%57.72M
-26.94%45.88M
-28.09%53.36M
-25.26%50.82M
-25.26%50.82M
-55.19%41.06M
-44.01%62.8M
-23.45%74.2M
-26.43%68M
-26.43%68M
Free cash flow
72.51%-7.54M
31.25%-13.09M
25.39%-29.74M
40.80%-98.88M
55.47%-12.57M
44.59%-27.41M
30.17%-19.03M
35.78%-39.86M
16.61%-167.02M
13.30%-28.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 73.67%-7.13M28.16%-12.43M25.73%-28.48M39.09%-95.21M53.62%-12.49M42.03%-27.07M26.55%-17.3M35.16%-38.35M15.02%-156.32M10.28%-26.93M
Net income from continuing operations 129.74%9.55M44.66%-25.59M37.24%-29.83M29.16%-159.6M51.46%-33.72M36.22%-32.1M3.27%-46.25M17.62%-47.53M-12.45%-225.3M-72.94%-69.47M
Depreciation and amortization -4.05%4.41M-10.01%4.5M-9.26%4.73M-13.38%19.26M-17.51%4.45M-20.34%4.59M-11.50%5M-3.85%5.21M6.27%22.23M2.01%5.39M
Other non cash items -97.02%56K-32.50%1.3M-29.48%1.67M-35.15%8.04M-14.45%1.86M-49.35%1.88M-36.73%1.93M-31.52%2.37M51.25%12.39M1.68%2.17M
Change In working capital -159.98%-33.87M-287.72%-5.31M-56.64%-16.14M62.21%-17.45M186.93%3.05M30.13%-13.03M529.40%2.83M57.89%-10.31M35.45%-46.18M66.50%-3.51M
-Change in receivables 89.70%-536K-110.95%-702K54.00%-1.86M-284.25%-3.74M86.71%-899K-1,658.08%-5.2M1,132.37%6.41M-144.60%-4.05M108.97%2.03M49.91%-6.77M
-Change in inventory -179.38%-1.35M111.61%95K-76.24%264K289.29%5.37M-14.96%3.38M721.61%1.7M-1,358.46%-818K116.82%1.11M-447.37%-2.84M31.30%3.98M
-Change in prepaid assets -80.41%-2.52M50.20%-497K-67.83%489K104.30%83K-52.80%960K67.69%-1.4M-239.00%-998K531.82%1.52M-154.35%-1.93M-31.05%2.03M
-Change in payables and accrued expense 10,093.22%5.9M703.19%3.27M-145.24%-9.67M112.41%671K-20.13%4.26M97.90%-59K-94.87%407K75.18%-3.94M-176.04%-5.41M-49.30%5.34M
-Change in other working capital -338.56%-35.36M-243.29%-7.47M-8.56%-5.37M47.85%-19.84M42.51%-4.65M30.31%-8.06M71.57%-2.18M53.89%-4.94M37.00%-38.04M39.95%-8.1M
Cash from discontinued investing activities
Operating cash flow 73.67%-7.13M28.16%-12.43M25.73%-28.48M39.09%-95.21M53.62%-12.49M42.03%-27.07M26.55%-17.3M35.16%-38.35M15.02%-156.32M10.28%-26.93M
Investing cash flow
Cash flow from continuing investing activities 226.90%17.28M-43.07%3.35M-42.54%25.57M-40.00%77.79M589.71%22.12M-79.77%5.29M-84.25%5.88M-29.33%44.51M4,362.89%129.65M103.29%3.21M
Net PPE purchase and sale -18.90%-409K62.12%-655K16.68%-1.26M65.75%-3.66M93.84%-80K87.62%-344K53.23%-1.73M48.32%-1.51M34.57%-10.7M48.94%-1.3M
Net investment purchase and sale 214.19%17.69M-47.40%4M-41.69%26.83M-41.96%81.46M392.76%22.2M-80.53%5.63M-81.46%7.61M-30.17%46.02M628.91%140.34M104.74%4.51M
Cash from discontinued investing activities
Investing cash flow 226.90%17.28M-43.07%3.35M-42.54%25.57M-40.00%77.79M589.71%22.12M-79.77%5.29M-84.25%5.88M-29.33%44.51M4,362.89%129.65M103.29%3.21M
Financing cash flow
Cash flow from continuing financing activities 4,110.00%1.68M5,266.67%1.61M12,288.64%5.45M-89.27%241K45.98%127K135.29%40K-97.96%30K-93.45%44K-98.30%2.25M1,350.00%87K
Proceeds from stock option exercised by employees 4,110.00%1.68M5,266.67%1.61M12,288.64%5.45M-89.27%241K45.98%127K135.29%40K-97.96%30K-93.45%44K-71.55%2.25M-72.98%87K
Cash from discontinued financing activities
Financing cash flow 4,110.00%1.68M5,266.67%1.61M12,288.64%5.45M-89.27%241K45.98%127K135.29%40K-97.96%30K-93.45%44K-98.30%2.25M1,350.00%87K
Net cash flow
Beginning cash position -26.94%45.88M-28.09%53.36M-25.26%50.82M-26.43%68M-55.19%41.06M-44.01%62.8M-23.45%74.2M-26.43%68M-34.54%92.43M-58.35%91.63M
Current changes in cash 154.47%11.84M34.42%-7.47M-59.03%2.54M29.69%-17.18M141.27%9.76M-5.89%-21.74M-174.80%-11.4M37.81%6.2M49.91%-24.43M81.47%-23.64M
End cash Position 40.58%57.72M-26.94%45.88M-28.09%53.36M-25.26%50.82M-25.26%50.82M-55.19%41.06M-44.01%62.8M-23.45%74.2M-26.43%68M-26.43%68M
Free cash flow 72.51%-7.54M31.25%-13.09M25.39%-29.74M40.80%-98.88M55.47%-12.57M44.59%-27.41M30.17%-19.03M35.78%-39.86M16.61%-167.02M13.30%-28.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -